AdvaMed commends China's measures to streamline regulatory process
China's health ministry and the State Food and Drug Administration will retain responsibilities regarding recalls of medical devices in an effort to prevent redundancies in recall regulations. The move is one of the measures for streamlining the regulatory process for devices announced by the Chinese government at a meeting of the U.S.-China Joint Commission on Commerce and Trade in Hangzhou, China.
Clinica (subscription required)
| 11/2
This story published in AdvaMed SmartBrief on 11/03/2009
Get stories like these delivered daily for FREE:
|
AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more |
|